TrialBritish journal of cancer2004

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

M Stendahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.